title: MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D.
abstract: High and low affinity receptors for basic fibroblast growth factor (bFGF) were detected by binding experiments on MCF7 breast cancer cells. These cells were stimulated for growth by physiological concentrations of bFGF. However, in contrast to endothelial cells, these MCF7 cells did not produce detectable amounts of biologically active bFGF or related heparin-binding growth factor(s) of the FGF family. In vitro, the cathepsin D (cath-D) secreted by MCF7 cells was able to digest extracellular matrix (ECM) and to release ECM-bound 125I-bFGF. When MCF7 cells were cultured on ECM containing bound bFGF, they internalized bFGF, which was slowly and partially proteolyzed in the cells. Processing occurred in acidic compartments and was inhibited by leupeptin. Pepstatin A, an inhibitor of aspartyl proteases, had no effect on the processing but reduced internalization of matrix-bound bFGF by MCF7 cells. Taken together, these results suggest a cooperation between cath-D and bFGF, by which the protease could facilitate the release of bFGF from ECM and its subsequent use by breast cancer cells and/or adjacent cells involved in angiogenesis.
authors.affiliation: INSERM U 148, Unit Hormones and Cancer, Montpellier, France.
authors.forename: P
authors.initials: P
authors.lastname: Briozzo
authors.forename: J
authors.initials: J
authors.lastname: Badet
authors.forename: F
authors.initials: F
authors.lastname: Capony
authors.forename: I
authors.initials: I
authors.lastname: Pieri
authors.forename: P
authors.initials: P
authors.lastname: Montcourrier
authors.forename: D
authors.initials: D
authors.lastname: Barritault
authors.forename: H
authors.initials: H
authors.lastname: Rochefort
mesh_terms: D001943:Breast Neoplasms; D002402:Cathepsin D / Q000378:metabolism*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D005109:Extracellular Matrix / Q000502:physiology*; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D010436:Pepstatins / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000378:metabolism*; D017468:Receptors, Fibroblast Growth Factor
chemical_list: D010436:Pepstatins; D011480:Protease Inhibitors; D011956:Receptors, Cell Surface; D017468:Receptors, Fibroblast Growth Factor; D016222:Fibroblast Growth Factor 2; C014195:Streptomyces pepsin inhibitor; D002402:Cathepsin D; C031375:pepstatin